PreveCeutical Medical Inc. (CSE:PREV)
0.0200
+0.0050 (33.33%)
Sep 17, 2026, 9:04 AM EST
PreveCeutical Medical Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
12.76M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Devonian Health Group | 3.00M |
| Rapid Dose Therapeutics | 2.58M |
| Glow Lifetech | 2.31M |
| Pharmala Biotech Holdings | 1.27M |
| Britannia Life Sciences | 406.44K |
| Kane Biotech | 38.72K |
| Alzai Health | 27.04K |
PreveCeutical Medical News
- 6 weeks ago - PreveCeutical Closes Fourth Tranche of Non-Brokered Private Placement - Newsfile Corp
- 7 weeks ago - PreveCeutical Closes Third Tranche of Non-Brokered Private Placement - Newsfile Corp
- 3 months ago - PreveCeutical Closes Second Tranche of Non-Brokered Private Placement - Newsfile Corp
- 3 months ago - BioGene Therapeutics Inc. Appoints Ty Howton to Board of Directors - Newsfile Corp
- 4 months ago - PreveCeutical Announces Extension of Non-Brokered Private Placement - Newsfile Corp
- 4 months ago - PreveCeutical Closes Initial Tranche of Non-Brokered Private Placement - Newsfile Corp
- 5 months ago - PreveCeutical Announces Non-Brokered Private Placement - Newsfile Corp
- 5 months ago - PreveCeutical Adopts Semi-Annual Financial Reporting - Newsfile Corp